Literature DB >> 14756711

Patterns of ecstasy use in Australia: findings from a national household survey.

Louisa Degenhardt1, Bridget Barker, Libby Topp.   

Abstract

AIM: To examine the patterns, correlates and context of 'recent' (preceding 12 months) ecstasy use using data from a nationally representative sample of Australians interviewed in 2001.
DESIGN: Data were analysed from the 2001 National Drug Strategy Household Survey, a multi-stage probability sample of Australians aged 14 years or older. The focus was on ecstasy use among 14-19-year-olds and 20-29-year-olds, as the prevalence of recent use is highest among these groups. Recent ecstasy users were compared to those who had not used in the preceding 12 months and those who had never tried ecstasy ('others') on a range of demographic and drug use variables. Comparisons were also drawn between the patterns and context of ecstasy use of the two groups of recent ecstasy users (users aged between 14-19 and 20-29 years).
FINDINGS: In 2001, 6.1% of Australians aged 14 years or older reported life-time ecstasy use, and 2.9% reported recent use. One in 10 (10.4%) of 20-29-year-olds and 5.0% of 14-19-year-olds had used ecstasy recently. Although there were few demographic differences between recent users and others, compared to those who had not recently used ecstasy, recent ecstasy users were more likely to have used a range of other drugs. Although recent ecstasy users of both age groups could be characterized as polydrug users, 20-29-year-old users were more likely to use other drugs concurrently with ecstasy.
CONCLUSIONS: Following cannabis and amphetamines, ecstasy is the third most widely used illicit drug in Australia. Other than a greater likelihood of having used other drugs, few demographic variables appear to distinguish recent ecstasy users from others. Australian users in their 20s use ecstasy within a context of greater polydrug use than those in their teens. Although most ecstasy users described a pattern of occasional use, minorities reported weekly use, and difficulties in reducing their use despite wishing to do so. There is a need to develop interventions to assist problematic ecstasy users to reduce their use should they wish to do so and to increase education about the potential risks of combining ecstasy with other drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14756711     DOI: 10.1111/j.1360-0443.2003.00622.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  16 in total

1.  Contextual profiles of young adult ecstasy users: A multisite study.

Authors:  Ujjwal P Ramtekkar; Catherine W Striley; Linda B Cottler
Journal:  Addict Behav       Date:  2010-10-29       Impact factor: 3.913

2.  Weekend Ecstasy use disrupts memory in rats.

Authors:  Leah M McAleer; Timothy Schallert; Christine L Duvauchelle
Journal:  Neurosci Lett       Date:  2013-05-22       Impact factor: 3.046

Review 3.  A developmental comparison of the neurobehavioral effects of ecstasy (MDMA).

Authors:  Brian J Piper
Journal:  Neurotoxicol Teratol       Date:  2006-10-20       Impact factor: 3.763

4.  MDMA effects consistent across laboratories.

Authors:  Matthew G Kirkpatrick; Matthew J Baggott; John E Mendelson; Gantt P Galloway; Matthias E Liechti; Cédric M Hysek; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2014-03-15       Impact factor: 4.530

5.  Self-Reported Ecstasy/MDMA/"Molly" Use in a Sample of Nightclub and Dance Festival Attendees in New York City.

Authors:  Joseph J Palamar; Patricia Acosta; Danielle C Ompad; Charles M Cleland
Journal:  Subst Use Misuse       Date:  2016-09-23       Impact factor: 2.164

6.  MDMA self-administration fails to alter the behavioral response to 5-HT(1A) and 5-HT(1B) agonists.

Authors:  Dane Aronsen; Susan Schenk
Journal:  Psychopharmacology (Berl)       Date:  2016-02-09       Impact factor: 4.530

7.  Repeated administration of the 5-HT₁B/₁A agonist, RU 24969, facilitates the acquisition of MDMA self-administration: role of 5-HT₁A and 5-HT₁B receptor mechanisms.

Authors:  Dane Aronsen; Natasha Bukholt; Susan Schenk
Journal:  Psychopharmacology (Berl)       Date:  2016-02-09       Impact factor: 4.530

8.  Quality of life of people who inject drugs: characteristics and comparisons with other population samples.

Authors:  Jane A Fischer; Sue Conrad; Alexandra M Clavarino; Robert Kemp; Jackob M Najman
Journal:  Qual Life Res       Date:  2013-01-23       Impact factor: 4.147

9.  Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Katherine M Keyes; Silvia S Martins; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2008-06-03       Impact factor: 4.492

10.  N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study.

Authors:  Ronald L Cowan; James M Joers; Mary S Dietrich
Journal:  Pharmacol Biochem Behav       Date:  2008-11-13       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.